Advanced-therapy medicinal product (ATMP) classification was confirmed for Oncos’ lead product ONCOS-102 by the Committee for Advanced Therapies (CAT) of European Medicines Agency. The report summary can be found here.
Advanced-therapy medicinal product (ATMP) classification was confirmed for Oncos’ lead product ONCOS-102 by the Committee for Advanced Therapies (CAT) of European Medicines Agency. The report summary can be found here.